Torrent Pharmaceuticals P/B Ratio
Torrent Pharmaceuticals (TORNTPHARM) P/B ratio is 17.96 (High), book value per share ₹496.39 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. Compare with Torrent Pharmaceuticals valuation methods to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
TORNTPHARM P/B Ratio — Valuation Insights & Book Value Analysis
Torrent Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 17.96 (High). View TORNTPHARM price range for the annual high/low range and current price position.
- Stock appears overvalued with PB of 17.96, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 160.4% above historical average
- Trading at premium to sector average PB of -0.33
Torrent Pharmaceuticals P/B Ratio Historical Trend
TORNTPHARM annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see TORNTPHARM screener.
TORNTPHARM Historical P/B Ratio — Book Value Per Share & Year-End Price
Torrent Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 9.14 | ₹496.39 | ₹4537.80 | ₹8,389 | High |
| 2025 | 8.57 | ₹449.17 | ₹3850.00 | ₹7,591 | High |
| 2024 | 8.28 | ₹405.68 | ₹3360.05 | ₹6,856 | High |
| 2023 | 6.29 | ₹366.75 | ₹2305.55 | ₹6,198 | High |
| 2022 | 2.21 | ₹700.35 | ₹1550.60 | ₹5,953 | Moderate |
TORNTPHARM vs Healthcare Peers — P/B Ratio Comparison
Torrent Pharmaceuticals P/B 17.96 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |